DAPI (4',6-Diamidino-2-Phenylindole, Dilactate)

Pricing & Availability
Regulatory Status
RUO
Other Names
4',6-Diamidino-2-Phenylindole, Dilactate
Ave. Rating
Submit a Review
Product Citations
publications
1_Ankita_Patil.jpg
Methanol fixed superior cervical ganglion neurons were stained with anti-tubulin β3 (pink) and anti-TRIM46 (aqua), then stained with secondary antibodies, phalloidin (orange) and DAPI (blue). Image generously submitted to the 2017 Cell Life Imaging Competition by Ankita Patil from Drexel University.
  • 1_Ankita_Patil.jpg
    Methanol fixed superior cervical ganglion neurons were stained with anti-tubulin β3 (pink) and anti-TRIM46 (aqua), then stained with secondary antibodies, phalloidin (orange) and DAPI (blue). Image generously submitted to the 2017 Cell Life Imaging Competition by Ankita Patil from Drexel University.
  • 2_Kathleen-Ignatoski
    Frozen mouse intestine stained with purified anti-Ankyrin-B (green), E-Cadherin (red) and DAPI (blue) followed by anti-goat Alexa Fluor® 488 and anti-rabbit Alexa Fluor® 568. Image generously submitted to the 2017 Cell Life Imaging Competition by Kathleen Ignatoski from University of Michigan.
  • 3_KifLiakath.jpg
    Whole mount mouse tail epidermis was stained with purified anti-Keratin 14 (green, clone Poly19053), purified anti-Keratin 15 (orange, clone Poly18339) and DAPI (blue). Image generously submitted to the 2017 Cell Life Imaging Competition by Kif Liakath.
  • 4_DAPI_IF_080712
    Human cervical cancer cell line, HeLa, was fixed with 4% paraformaldehyde and stained with 300 nM DAPI.
  • 5_DAPI_080712
    Human cervical cancer cell line, HeLa, was fixed with 4% paraformaldehyde and stained with 300 nM DAPI.
See DAPI (4',6-Diamidino-2-Phenylindole, Dilactate) spectral data
Cat # Size Price Save
422801 10 mg ¥19,740
Description

DAPI (4',6-Diamidino-2-Phenylindole, Dilactate), a blue fluorescent nucleic acid stain, preferentially binds dsDNA and associates with the minor groove AT clusters. The molecular weight for DAPI is 457.5.  Association of DAPI with dsDNA increases fluorescence approximately 20-fold, with an emission maximum of 460 nm. The increase in fluorescence is believed to be due to displacement of water molecules from the minor groove and DAPI. DAPI can also bind RNA and emits at a longer wavelength of 500 nm, with only a 20% increase in fluorescence.

DAPI is a popular nuclear stain for identification of cell cycle and specifically stains nuclei but not cytoplasm. The dilactate form is more water soluble compared to the dihydrochloride form.

DAPI can be excited by a UV laser, xenon, or a mercury-arc lamp. 

Product Details
Technical data sheet

Product Details

Formulation
Lyophilized
Preparation
To make 5 mg/ml (10.9 mM) solution, dissolve entire contents of vial in 2 ml of deionized water.
Storage & Handling
Store between 2°C and 8°C, protected from light. For long term storage, aliquot and store at -20°C.
Application

ICFC, ICC

Recommended Usage

This product can be used at 3 µM for flow cytometry and 300 nM for immunofluorescence.  It is recommended to titrate the dye for optimal performance. 

Excitation Laser
Ultraviolet Laser (355 nm)
Application Notes

Protocols for Counterstaining with DAPI:

Immunofluorescence Staining
Note: Cells may be fixed by method of choice, such as with 4% paraformaldehyde. DAPI staining is done after staining for other markers. Fixation and permeabilization of cells is not necessary to counterstain with DAPI.

1. Fix cells using method of choice.
2. Incubate the cells with phosphate buffered saline (PBS) for 15 minutes.
3. Dilute the DAPI solution (we recommend to 300 nM) with PBS. Remove excess PBS from the slide and cover with DAPI solution, making sure the cells are completely covered.
4. Incubate for up to 5 minutes. Rinse the slide several times to remove all free DAPI. It is recommended to use a mounting medium with antifade reagent to reduce fluorescence quenching. The slide is ready to view under the microscope with appropriate filters.


Nuclear Staining for Flow Cytometry
Note: Cells may be fixed with 4% paraformadehyde or absolute ethanol.

1. Fix cells with absolute ethanol or 4% paraformaldehyde.
2. Centrifuge, discard the supernatant, and add 5 ml of PBS, allowing cells to rehydrate for 15 minutes.
3. Dilute the DAPI to 3 µM (recommended) in staining buffer (such as BioLegend's FOXP3 Perm Buffer, Cat. No. 421402).
4. Centrifuge cell suspension from step 3 above, discard supernatant, and add 1 ml of DAPI solution; then incubate at room temperature for 15 minutes.
5. Analyze by flow cytometry using an instrument with appropriate lasers.

Additional Product Notes

View more applications data for this product in our Scientific Poster Library.

Application References

(PubMed link indicates BioLegend citation)
  1. Solomonov I, et al. 2014. Sci Rep. 4:5987. PubMed
  2. Sodhi CP, et al. 2015. J Immunol. 194:4931. PubMed
Product Citations
  1. Davila ML, et al. 2022. iScience. 25:104426. PubMed
  2. Grubwieser P, et al. 2022. Front Cell Infect Microbiol. 12:875543. PubMed
  3. Sierro F, et al. 2017. Immunity. 47:374. PubMed
  4. Rodrigues M, et al. 2022. Biochem J. 479:1891. PubMed
  5. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  6. Effern M, et al. 2022. STAR Protoc. 3:101038. PubMed
  7. Sountoulidis A, et al. 2020. PLoS Biol. 18:e3000675. PubMed
  8. Mester B, et al. 2015. PLoS One. 10: e0140432. PubMed
  9. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  10. Velilla J, et al. 2019. Neurol Genet. 5:e312. PubMed
  11. Jiao Q, et al. 2017. Clin Exp Immunol. 188:420. PubMed
  12. Anguiano T, et al. 2020. Toxicol Sci. 177:494. PubMed
  13. Afshar Y, et al. 2021. Nat Commun. 12:4408. PubMed
  14. Goodnough LH, et al. 2022. Front Endocrinol (Lausanne). 13:924927. PubMed
  15. Nguyen DT, et al. 2022. Cells. 11:. PubMed
  16. Baldominos P, et al. 2022. STAR Protoc. 3:101795. PubMed
  17. Wilson K, et al. 2016. Cell Death Dis. 7: e2197. PubMed
  18. Kobayashi T, et al. 2019. Cell. 176:982. PubMed
  19. Miedema A, et al. 2022. Acta Neuropathol Commun. 10:8. PubMed
  20. Emmons TR, et al. 2021. Cancer Immunol Res. 9:790. PubMed
  21. Valkov N, et al. 2021. Life Sci Alliance. 4:. PubMed
  22. Gamboa CM, et al. 2021. STAR Protoc. 100345:2. PubMed
  23. Sugawara E, et al. 2020. Autophagy. 1.323611111. PubMed
  24. Elias A, et al. 2016. Sci Rep. 6: 24971. PubMed
  25. Bannard O, et al. 2016. J Exp Med. 13: 993 - 1009. PubMed
  26. Sumitomo Y, et al. 2016. Blood. 128: 1614 - 1624. PubMed
  27. Paris AJ, et al. 2020. Nat Cell Biol. 1.747916667. PubMed
  28. Brunner JS, et al. 2020. Nat Commun. 0.757638889. PubMed
  29. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  30. Alexander MS, et al. 2021. Muscle Nerve. 63:928. PubMed
  31. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  32. Hiramatsu-Asano S, et al. 2021. Front Immunol. 11:616141. PubMed
  33. Ambrosi TH, et al. 2021. Elife. 10: . PubMed
  34. Hopp AK, et al. 2021. Mol Cell. 81:340. PubMed
  35. Zhang M, et al. 2017. Oncol Lett. 3.069444444. PubMed
  36. Greenblatt SM, et al. 2018. Cancer Cell. 33:1111. PubMed
  37. Wilson AS, et al. 2022. Nat Commun. 13:528. PubMed
  38. Deng J, et al. 2021. Breast Cancer Res Treat. 185:85. PubMed
  39. DeDreu J, et al. 2020. FASEB J. 34:9316. PubMed
  40. Allam O, et al. 2018. PLoS One. 13:e0194185. PubMed
  41. Fujiwara H, et al. 2021. Nat Immunol. 22:1440. PubMed
  42. Ravi A, et al. 2021. Dev Cell. 56:1661. PubMed
  43. Wu CL, et al. 2021. Nat Commun. 12:362. PubMed
  44. Koh P, et al. 2016. Sci Data. 3:160109. PubMed
  45. Sodhi C, et al. 2015. J Immunol. 194:4931. PubMed
  46. Kanda K, et al. 2018. JCI Insight. 3:e91316. PubMed
  47. So EY, et al. 2021. Am J Physiol Cell Physiol. 321:C569. PubMed
  48. Poulos M, et al. 2016. Nat Commun. 7:13829. PubMed
  49. Noah AC, et al. 2020. J Appl Physiol (1985). 473:128. PubMed
  50. Wang ECE, et al. 2019. Cell Stem Cell. 24:654. PubMed
  51. Wennerberg E, et al. 2022. Sci Transl Med. 14:eabe8195. PubMed
  52. Kumar A, et al. 2021. STAR Protoc. 2:100874. PubMed
  53. Hendricks A, et al. 2020. Cancers (Basel). 12:00. PubMed
  54. Aronovich A, et al. 2021. J Invest Dermatol. 141:619. PubMed
  55. Teo YV, et al. 2019. Cell Rep. 27:997. PubMed
  56. Hayama Y, et al. 2018. J Immunol. 200:3790. PubMed
  57. Fredriksson-Lidman K, et al. 2017. PLoS One. 10.1371/journal.pone.0185509. PubMed
  58. Caeser R, et al. 2021. Nat Protoc. 16:2499. PubMed
  59. Faisal S, et al. 2016. Sci Rep. 6:39530. PubMed
  60. Zhang X, et al. 2022. JCI Insight. 7:. PubMed
  61. Zhu M, et al. 2021. Eneuro. 8:. PubMed
  62. Flores-Pliego A, et al. 2021. Cells. 10:. PubMed
  63. Shani O, et al. 2021. Elife. 10: . PubMed
  64. Thompson M, et al. 2015. J Immunol. 195: 5637 - 5647. PubMed
  65. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  66. Pagan JD, et al. 2018. Cell. 172:564. PubMed
  67. Heath O, et al. 2021. Cancer Immunol Res. 9:665. PubMed
  68. Dasinger JH, et al. 2021. Pregnancy Hypertens. 24:126. PubMed
  69. Ren X, et al. 2022. STAR Protoc. 3:101818. PubMed
  70. Moser J, et al. 2016. Sci Rep. 6:35387. PubMed
  71. Mould KJ, et al. 2019. JCI Insight. 4:00. PubMed
  72. Pascual-Pasto G, et al. 2022. J Immunother Cancer. 10:. PubMed
  73. Lehrke MJ, et al. 2021. Elife. 10:. PubMed
  74. Wang Y, et al. 2021. EMBO Mol Med. 13:e14089. PubMed
  75. Correa A, et al. 2015. PLoS One. 10: 0143391. PubMed
  76. Yanting C, et al. 2018. J Dairy Sci. 101:1601. PubMed
  77. Kurena B, et al. 2017. Front Immunol. 1.490972222. PubMed
  78. Pinho–Ribeiro FA, et al. 2018. Cell. 173:1083. PubMed
  79. Aziz M, et al. 2017. J Immunol. 10.4049/jimmunol.1602056. PubMed
  80. Valdespino-Vázquez MY, et al. 2021. J Med Virol. 93:4480. PubMed
  81. Kissiov DU, et al. 2022. Elife. 11:. PubMed
  82. Isobe T, et al. 2022. Nat Commun. 13:4501. PubMed
  83. Chiang M, et al. 2019. Cell Rep. 28:3212. PubMed
  84. Canals Hernaez D, et al. 2022. Front Oncol. 12:856424. PubMed
  85. Mascharak S, et al. 2022. Cell Stem Cell. 29:315. PubMed
  86. Rodriguez A, et al. 2021. Cell Stem Cell. 28:33. PubMed
  87. Pang J, et al. 2021. STAR Protoc. 2:100879. PubMed
  88. Haschak M, et al. 2021. Aging (Albany NY). 13:16938. PubMed
  89. Phan TS, et al. 2021. Sci Adv. 7:. PubMed
  90. Stancil IT, et al. 2021. Nat Commun. 12:4566. PubMed
  91. Margaroli C, et al. 2021. Cell Rep Med. :100242. PubMed
  92. Caporarello N, et al. 2020. Aging Cell. 19:e13196. PubMed
  93. Vergoni B, et al. 2016. Diabetes. 65: 3062 - 3074. PubMed
  94. Dent JR, et al. 2019. J Appl Physiol (1985). 127:1117. PubMed
  95. Schmidt A, et al. 2017. Toxicol Lett. 10.1016/j.toxlet.2017.08.008. PubMed
  96. Burns F, et al. 2015. Aquatic Toxicology. 164: 52-60. PubMed
  97. Stevens M, et al. 2016. Nat Biotechnol. 34:1161-1167. PubMed
  98. Shilts J, et al. 2021. Sci Rep. 0.745138889. PubMed
  99. Zheng C, et al. 2022. Acta Pharm Sin B. 12:3726. PubMed
  100. Anisul M, et al. 2021. Elife. 10:. PubMed
  101. Pelham-Webb B, et al. 2021. Mol Cell. 81:1732. PubMed
  102. Kohn M, et al. 2021. Front Immunol. 626627:12. PubMed
  103. Jain A, et al. 2020. Nat Immunol. 0.920138889. PubMed
  104. Aimi F, et al. 2021. Mod Pathol. 34:1468. PubMed
  105. Barcia Durán JG, et al. 2021. Commun Biol. 4:406. PubMed
  106. Karimzadeh A, et al. 2021. Front Cell Dev Biol. 9:734176. PubMed
  107. Reeves KM, et al. 2021. Clin Cancer Res. Online ahead of print. PubMed
  108. Chmielewski M and Abken H 2017. Cell Rep.. 10.1016/j.celrep.2017.11.063. PubMed
  109. Hassanein W, et al. 2017. Organogenesis. 13:16. PubMed
  110. Guo P, et al. 2022. Nat Cell Biol. 24:99. PubMed
  111. Tominaga K, et al. 2022. iScience. 25:103667. PubMed
  112. Chen HY, et al. 2020. J Immunol. 1158:204. PubMed
  113. Gosztyla C, et al. 2020. Tissue Eng Part C Methods. 26:67. PubMed
  114. Köhler VK, et al. 2020. Int J Mol Sci. 21:00. PubMed
  115. Solomonov I, et al. 2014. Sci Rep. 4:5987. PubMed
  116. Srijiwangsa P, et al. 2018. BMC Pharmacol Toxicol. 19:32. PubMed
  117. Ladd MR, et al. 2018. Tissue Eng Part C Methods. 24:331. PubMed
  118. Bennett AH, et al. 2018. PLoS Genet. 14:e1007226. PubMed
  119. Doorley L, et al. 2017. Immunobiology.. 10.1016/j.imbio.2017.08.002. PubMed

Antigen Details

Biology Area
Cell Biology, Cell Cycle/DNA Replication, Neuroscience
Antigen References

1. Langlois RG, et al. 1980. Chromosoma. 77:229.
2. Kubista M, et al. 1987. Biochemistry 26:4545.

Gene ID
NA

Related FAQs

There are no FAQs for this product.
Go To Top Version: 1    Revision Date: 11/30/2012

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account